Asthma complicating pregnancy is coded in ICD-10-CM using a dual-code approach: a code from the O99.51x family identifies the pregnancy complication and trimester, while a secondary code from the J45 category specifies the type, severity, and current status of the asthma itself. Getting both codes right matters more than it might seem, because the severity and control distinctions captured in the J45 code correspond to genuinely different risk profiles for both mother and baby. The clinical stakes behind these coding choices are what make this particular corner of ICD-10 worth understanding in detail.
The Primary Code and Trimester Selection
The starting point is always a code from the O99.51 range. These codes fall under Chapter 15 of ICD-10-CM, which covers pregnancy, childbirth, and the puerperium. The “x” in O99.51x is the trimester digit:
- O99.511: Diseases of the respiratory system complicating pregnancy, first trimester
- O99.512: Second trimester
- O99.513: Third trimester
- O99.519: Unspecified trimester
There are also codes for the childbirth and puerperium phases: O99.512 applies during labor and delivery, and O99.53 covers the postpartum period. Note that O99.51x is not asthma-specific. It captures any respiratory disease complicating pregnancy, which is exactly why a secondary code is needed to tell the full story. The O99.51x code should be sequenced first, followed by the J45 code, following the ICD-10-CM convention that pregnancy chapter codes take priority when a pre-existing condition complicates gestation.
Trimester assignment follows standard ICD-10-CM definitions: first trimester runs through the end of week 13, second trimester covers weeks 14 through 27, and third trimester starts at week 28. When documentation does not specify the trimester, O99.519 is the fallback, but coders should query the provider rather than default to “unspecified” whenever possible, since trimester-specific data feeds into quality metrics and outcomes tracking.
Specifying Asthma Severity With the J45 Code
The J45 family is where clinical precision lives. ICD-10-CM distinguishes four severity tiers and several status modifiers:
- Mild intermittent (J45.2x): Symptoms two or fewer days per week, nighttime awakenings no more than twice a month
- Mild persistent (J45.3x): Symptoms more than twice weekly but not daily
- Moderate persistent (J45.4x): Daily symptoms, nighttime awakenings more than once a week
- Severe persistent (J45.5x): Symptoms throughout the day, frequent nighttime awakenings, limited physical activity
Within each severity tier, the final digit captures what is happening right now: 0 for uncomplicated, 1 for acute exacerbation, and 2 for status asthmaticus (a severe, prolonged attack that does not respond to standard bronchodilator therapy). There is also a catch-all J45.90x range for “unspecified asthma” when the documentation lacks enough detail to classify severity, though this should be a last resort.
For a pregnant patient with moderate persistent asthma who presents in her second trimester without an active exacerbation, the correct code pair would be O99.512 plus J45.40. If that same patient arrives in the emergency department during an acute flare, the pair shifts to O99.512 plus J45.41. The distinction between “uncomplicated” and “with exacerbation” is not just administrative bookkeeping. It reflects a meaningful clinical boundary.
Why Severity Classification Carries Clinical Weight
Asthma affects roughly 8 to 10 percent of pregnant women, making it the most common chronic respiratory condition in pregnancy.1Karger. Treatable Traits in Pregnant Women with Asthma The condition does not behave the same way in every pregnant patient. In a study tracking over 300 women with asthma through pregnancy, about 60 percent followed a “same” trajectory with stable and infrequent symptoms, while roughly 40 percent followed a “worse” trajectory with increasing nighttime symptoms and greater inhaler use as pregnancy progressed.2PubMed Central. Determining the clinical course of asthma in pregnancy A systematic review found that bronchial hyperresponsiveness actually improved during pregnancy in about two-thirds of women, with the improvement peaking in the second trimester and reverting after delivery, but worsened in the remaining third.3PubMed. Effect of pregnancy and stage of pregnancy on asthma severity: a systematic review
This split is exactly why the J45 severity codes exist. A pregnant patient whose asthma is mild and well-controlled faces a very different risk landscape than one whose asthma is moderate-to-severe and poorly controlled. The code on the claim should reflect that difference.
Maternal Risks Tied to Uncontrolled Asthma
The link between asthma control and pregnancy complications is one of the strongest reasons to code severity accurately. A meta-analysis of cohort studies found that maternal asthma raised the risk of pregnancy-induced hypertension by about 45 percent and the risk of preeclampsia by about 43 percent compared to non-asthmatic pregnancies.4PubMed. Maternal asthma and the risk of hypertensive disorders of pregnancy: a systematic review and meta-analysis of cohort studies The risk of eclampsia, the more dangerous seizure-related form of hypertensive disease, was roughly 56 percent higher.
Control status compounds these risks. Data from the Vitamin D Antenatal Asthma Reduction Trial showed that women with a higher proportion of uncontrolled asthma months during pregnancy had more than triple the adjusted odds of developing preeclampsia compared to those whose asthma stayed controlled.5PubMed Central. The Association of Maternal Asthma and Early Pregnancy Vitamin D with Risk of Preeclampsia: An Observation from Vitamin D Antenatal Asthma Reduction Trial That threefold difference is not a subtle statistical finding. It represents a clinically meaningful gap that should be visible in the medical record, and coding is one of the ways that visibility is preserved.
Fetal and Neonatal Risks
The fetus is not insulated from maternal asthma, particularly when exacerbations occur. A large meta-analysis found that asthma exacerbations during pregnancy tripled the risk of low birth weight, and moderate-to-severe asthma was associated with roughly a 24 percent increased risk of the infant being small for gestational age.6European Respiratory Journal. Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomes A population-based study confirmed that exacerbations were tied to increased odds of both elective and emergency cesarean delivery, and women who experienced multiple exacerbations had more than two and a half times the odds of having a small-for-gestational-age infant.7ERJ Open Research. Effect of maternal asthma exacerbations on perinatal outcomes: a population-based study
These findings reinforce why the exacerbation modifier in the J45 code is not trivial. An encounter coded as J45.41 (moderate persistent with exacerbation) rather than J45.40 (moderate persistent, uncomplicated) captures a clinical event that has measurable downstream consequences for the pregnancy. For facilities tracking quality indicators, these codes feed directly into risk-adjustment models.
Treatment Documentation and Coding Interactions
One of the more fraught areas of asthma management in pregnancy is medication use, and the treatment decisions documented in the chart should align with the severity coded. Inhaled corticosteroids are considered the backbone of asthma maintenance therapy during pregnancy and are generally safe at low to moderate doses.8PubMed Central. Is it safe to use inhaled corticosteroids in pregnancy? The safety profile of long-acting beta-agonists used alongside inhaled corticosteroids is less firmly established, though recent evidence has been supportive.9PubMed Central. Safety of bronchodilators and corticosteroids for asthma during pregnancy: what we know and what we need to do better
Where treatment documentation becomes a coding issue is in the emergency setting. Research has found that pregnant women presenting to the emergency department with acute asthma were significantly less likely to receive systemic corticosteroids than non-pregnant women with the same condition: about 51 percent of pregnant women received systemic steroids compared to 72 percent of non-pregnant controls. At discharge, only 41 percent of pregnant patients received prednisone prescriptions versus 69 percent of non-pregnant patients.10PubMed. Pregnancy related treatment disparities of acute asthma exacerbations in the emergency department This treatment gap likely reflects provider caution about steroid use in pregnancy, but guidelines for severe exacerbations, including critical asthma syndrome, endorse aggressive bronchodilator therapy and systemic corticosteroids even during pregnancy.11PubMed. Management of critical asthma syndrome during pregnancy
From a coding standpoint, the issue is that an under-treated exacerbation may not appear in the chart the way a fully treated one would. If a pregnant patient presents with an acute flare but is sent home without systemic steroids and without clear documentation of the exacerbation severity, the encounter may end up coded as uncomplicated asthma rather than an exacerbation. That gap hides both the clinical event and the treatment disparity from downstream analytics.
Distinguishing Asthma From Physiologic Dyspnea
Shortness of breath is common in pregnancy even without asthma. The uterus pushes the diaphragm upward, progesterone stimulates the respiratory drive, and blood volume increases. These changes can produce a sensation of breathlessness that has nothing to do with airway obstruction. A study of dyspnea in pregnancy found that when breathlessness is accompanied by cough or wheezing, asthma is the likely cause, and evaluation with a physical exam and bronchodilator response can distinguish the two.12PubMed. Frequency of asthma as the cause of dyspnea in pregnancy
Lung function data adds nuance. Pregnant women with asthma had a baseline forced expiratory volume about 9 percent lower than women without asthma. Interestingly, forced vital capacity declined slightly across gestation in all women, but the FEV1 ratio actually improved over time in women with asthma, suggesting some degree of gestational bronchodilation in that group.13The Journal of Allergy and Clinical Immunology: In Practice. Longitudinal Pulmonary Function in Pregnant Women With and Without Asthma For coding purposes, a confirmed asthma diagnosis warrants the O99.51x plus J45.x pair; physiologic dyspnea of pregnancy, by contrast, does not belong under those codes. Miscoding normal pregnancy breathlessness as asthma inflates the apparent burden of disease, while missing true asthma behind the assumption that “all pregnant women feel short of breath” leaves real disease untracked.
Comorbidities That May Need Additional Codes
Asthma in pregnancy rarely travels alone. A review of treatable traits in pregnant women with asthma flagged several commonly overlapping conditions: obesity, rhinitis, gastroesophageal reflux disease, chronic rhinosinusitis (with or without nasal polyps), depression, anxiety, and sleep apnea.1Karger. Treatable Traits in Pregnant Women with Asthma Each of these conditions has its own ICD-10-CM code and, when documented as complicating pregnancy, its own O99 or O24/O26 category code. A pregnant patient with asthma, obesity, and gestational reflux might carry O99.512 + J45.40 for the asthma, O99.21x for the obesity, and a K21 code for the reflux.
The immunological backdrop of pregnancy itself plays a role. Pregnancy shifts the immune system toward an anti-inflammatory profile: regulatory T cells become more active, inflammatory cytokines decrease, and hormones like progesterone and estradiol modulate the balance.14PubMed Central. Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis For some women, this shift calms asthma; for others, it does not overcome the worsening mechanical and physiological stresses of advancing pregnancy. Comorbidities like rhinitis and reflux can trigger asthma symptoms independently, making it harder to classify control status and choose the right J45 code unless the provider explicitly documents what is driving the patient’s symptoms.
Racial Disparities in Asthma Morbidity During Pregnancy
Coding accuracy also intersects with health equity. A study of asthma morbidity during pregnancy found that Black women were nearly twice as likely as White women to have an emergency department visit for asthma during pregnancy, about 73 percent more likely to be hospitalized for asthma, and 35 percent more likely to require a course of rescue corticosteroids.15Obstetrics & Gynecology. Racial Differences in Asthma Morbidity During Pregnancy These disparities existed after adjustment for asthma severity, suggesting that differences in access, treatment patterns, or environmental exposures contribute beyond what severity classification alone captures.
For health systems trying to measure and close these gaps, the ICD-10 codes on claims data are the primary signal. If exacerbations are under-coded, or if severity is not documented precisely enough to generate the correct J45 code, the disparity becomes invisible in administrative datasets. A study comparing pregnancy-related variables in administrative databases against medical charts found that variables derived from linked databases were highly valid, but that validity depends on accurate initial coding.16Pharmacoepidemiology and Drug Safety. Agreement between administrative databases and medical charts for pregnancy-related variables among asthmatic women The data used to identify disparities is only as good as what clinicians put in the chart and coders translate to the claim.
Long-Term Offspring Outcomes and Why Maternal Severity Codes Matter Beyond the Pregnancy
The consequences of maternal asthma extend past delivery. Maternal asthma is associated with increased risks of neonatal respiratory distress syndrome, childhood wheeze, and childhood asthma itself, likely through a combination of genetic predisposition and the influence of the in-utero environment on fetal lung and immune development.17PubMed. The impact of maternal asthma on the fetal lung: Outcomes, mechanisms and interventions The risk to offspring tracks with the mother’s asthma severity and control during pregnancy. Children of mothers with moderate-to-severe uncontrolled asthma had about 37 percent higher prevalence of early-onset persistent asthma compared to children of mothers whose mild asthma was well-controlled. Even moderate-to-severe controlled asthma carried about a 33 percent increase.18PubMed. Maternal asthma severity and control during pregnancy and risk of offspring asthma
For researchers studying intergenerational respiratory health, maternal ICD-10 codes during pregnancy are often the starting point for identifying cohorts and stratifying by exposure severity. A J45.50 (severe persistent, uncomplicated) on a pregnancy claim tells a different story than a J45.20 (mild intermittent, uncomplicated), and that difference has downstream relevance for the child’s risk profile. When severity is left unspecified or coded generically as J45.909, researchers lose the ability to study these dose-response relationships using administrative data.
Common Pitfalls in Practice
A few recurring errors trip up both coders and clinicians documenting asthma in pregnancy:
- Omitting the O99.51x code: Coding only the J45 code without the pregnancy chapter code misses the complication relationship entirely. The O code must come first to signal that a pre-existing condition is affecting the pregnancy.
- Using J45.909 by default: “Unspecified asthma, uncomplicated” is a legitimate code, but it should be a last resort. If the chart documents severity and exacerbation status, the code should reflect that.
- Wrong trimester digit: A patient seen at 27 weeks and 5 days is still in the second trimester. Miscounting weeks against the trimester boundaries shifts the code.
- Confusing exacerbation with status asthmaticus: The final-digit distinction between 1 (exacerbation) and 2 (status asthmaticus) reflects a specific clinical threshold. Status asthmaticus means the patient is not responding to initial bronchodilator therapy, which is a different level of severity and resource use.
- Missing the postpartum window: If asthma complicates the puerperium (generally up to six weeks after delivery), the O99.53 code applies. Once the postpartum period ends, the encounter reverts to standard J45 coding without the pregnancy chapter overlay.
Each of these errors either understates the clinical picture or misattributes the timing, and both distortions affect reimbursement accuracy, quality reporting, and the reliability of population-level data drawn from claims.